Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

88
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
88
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

324
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
324
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

490
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
490

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementation of Mobile-Based Programs for Alcohol Cessation in the Treatment of Alcohol-associated Liver Disease: Protocol for a Type 1 Hybrid Implementation-Effectiveness Trial.

JMIR research protocols·2026
Same author

Lessons learned from viral hepatitis testing that inform law and policy responses to steatotic liver disease.

Nature reviews. Gastroenterology & hepatology·2026
Same author

Identification of modifiable plasma protein markers of cardiometabolic risk in children and adolescents with obesity.

Nature communications·2026
Same author

Young Adults Are at Highest Risk of Liver Fibrosis and Mortality Associated With Steatotic Liver Disease With Metabolic Dysfunction and Alcohol Consumption.

Hepatology research : the official journal of the Japan Society of Hepatology·2025
Same author

Integrated Alcohol Use Disorder and Liver Disease Management.

Seminars in liver disease·2025
Same author

Marked Variation in Hepatic Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease Over 5 Years: A Community-Based Study Using Controlled Attenuation Parameter.

United European gastroenterology journal·2025
Same journal

Financial burden among liver transplant candidates is associated with financial distress and work impairment: A U.S. multicenter study.

Hepatology communications·2026
Same journal

Neoadjuvant therapy in primary liver cancer: From the missing piece to a new paradigm.

Hepatology communications·2026
Same journal

Hepatology e-consult responses generated by artificial intelligence demonstrate accuracy but require human oversight.

Hepatology communications·2026
Same journal

The Transitional Liver Clinic: Study protocol for a stepped-wedge cluster randomized trial.

Hepatology communications·2026
Same journal

Methylation plus alpha-fetoprotein blood test for early detection of HCC in at-risk populations.

Hepatology communications·2026
Same journal

The PERK-GADD45A axis is a key driver of hepatic stellate cell activation.

Hepatology communications·2026
See all related articles

Related Experiment Video

Updated: Jun 15, 2025

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

20.1K

Population screening for cirrhosis.

Maja Thiele1,2, Elisa Pose3,4,5,6, Adrià Juanola3,4,5,6

  • 1Department of Gastroenterology and Hepatology, Center for Liver Research, Odense University Hospital, Odense, Denmark.

Hepatology Communications
|August 26, 2024
PubMed
Summary
This summary is machine-generated.

Screening for liver cirrhosis can improve outcomes, but more research is needed. Randomized trials must confirm benefits and optimize screening tests to avoid harms like overdiagnosis and increased costs.

More Related Videos

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
12:40

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Published on: May 19, 2018

10.2K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.1K

Related Experiment Videos

Last Updated: Jun 15, 2025

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

20.1K
Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
12:40

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Published on: May 19, 2018

10.2K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.1K

Area of Science:

  • Hepatology
  • Public Health
  • Diagnostic Medicine

Background:

  • Liver cirrhosis poses a significant health burden, increasing morbidity and mortality.
  • Early detection through screening is crucial for timely intervention and improved patient outcomes.
  • Current guidelines recommend targeted screening for high-risk populations.

Purpose of the Study:

  • To review current liver cirrhosis screening strategies.
  • To identify the promises and challenges of early cirrhosis detection methods.
  • To highlight knowledge gaps hindering widespread screening program implementation.

Main Methods:

  • Comprehensive literature review of cirrhosis screening strategies.
  • Analysis of evidence for screening's impact on case finding and lifestyle changes.
  • Evaluation of current diagnostic tests and their limitations (e.g., FIB-4).

Main Results:

  • Screening effectively increases case finding in at-risk populations.
  • Evidence suggests screening may prompt beneficial lifestyle changes in steatotic liver disease patients.
  • Major gaps exist regarding screening's impact on liver-related mortality and morbidity.

Conclusions:

  • Randomized trials are essential to validate screening's clinical utility and ethical implications.
  • Optimization of screening tests is needed to reduce false positives and negatives.
  • Addressing barriers to screening adherence and program implementation is critical.